- William E. Lyddane
- Jonathan R. Miller*
- Daniel B. Moon
- Robert W. Mueller
- Sean C. Myers-Payne, Ph.D.
- Naoko Ohashi*
- Enoch E. Peavey
- P. Branko Pejic*
- William Pieprz
- Steven Pollicoff*
- John Preta*
- James L. Rowland
- Stephen M. Roylance
- Kenneth H. Salen
- Walter Schlapkohl, Ph.D.
- Bruce H. Stoner, Jr.
- Arnold Turk
- Christopher L. Wright, Ph.D.*
- Patent Agents
- Patent Specialists
Jill M. Browning
Firm Practice Areas/Practice Groups
Litigation and Trial
Reexamination, Post Grant and Inter Partes Review Proceedings
Interference and Derivation
Patent Attorney – Greenblum and Bernstein, P.L.C. - 2009-Present
Patent Attorney – Private Practice - 2006-2009
Patent Attorney - Greenblum and Bernstein, P.L.C. - 1996-2006
Pro Se Law Clerk to Judges Cacheris, Hilton, Ellis and Brinkema, U.S. District Court for the Eastern District of Virginia – 1993-1996
Member, Board of Directors, Association of Patent Law Firms (2001-2007)
Vice President, Association of Patent Law Firms (2002-2003; 2005-2007)
Secretary, Association of Patent Law Firms (2003-2004)
Intellectual Property Owners - Licensing Committee (2007-20015)
Intellectual Property Owners – Post-Grant Committee (2016 – Present)
Lead and back up lead counsel in multiple interference proceedings.First and Second Chair jury and non-jury trial experience.
Professional Associations and MembershipsLicensing Executive Society
Intellectual Property Owners Association(Licensing Committee)
Virginia State Bar Association (Intellectual Property Committee)
Women in Technology
Virginia Bar Association
PTAB Bar Association
Browning, J., Vorozhbit, S., (November 2015). “Seeking Clarity Regarding the BPCIA.” Journal of Generic Medicines Sector, June 2015; vol. 12, 2: pp. 74-78.
Browning, J. (March 2013). “Supreme Court to Resolve Legality of ‘Reverse Payment’ Settlement Agreements Between Brand-Name Drug Manufacturers and Generic Competitors.” 10 Journal of Generic Medicines 39-45.
Browning, J., (October 2011). “Supreme Court Revisits Standard for Inducement to Infringe and Standard to Invalidate Patents.” 8 Journal of Generic Medicines 240-244
Bailey, N., Browning, J., (January 2010). “What Does the Bilski Hearing Tell Us?” IEEE-USA Today’s Engineer.
Browning, J., (November 9, 2009). “Supreme Court Hears Bilski v. Kappos,” Patently-O Patent Law Blog.
Browning, J., (2009). “Local Patent Rules Becoming More of a Factor in Popular Patent Jurisdictions.” 6-4 Journal of Generic Medicines 379-86.
Browning, J., (February 8, 2008). “Tafas v. Dudas: Summary Judgment Hearing,” Patently-O Patent Law Blog.
Browning, J., (October 31, 2007). “PTO Continuation and Claim Rules Temporarily Blocked by District Court.” Patently-O Patent Law Blog.
Stoner, B., Browning, J., (February 11, 2007). “Deposition Do’s and Don’ts: The Patent Interference Bar Is Warned.” Patently-O Patent Law Blog.
Browning, J., (2006). “When is the Confidential In-house Use of a Claimed Process a ‘Public Use’?” 3-2 Journal of Generic Medicines 161-64.
EducationUniversity of Virginia, B.A. in Chemistry with a Specialization in Biochemistry (1988)
The University of Virginia School of Law, J.D. (1993)
Supreme Court of Virginia
U.S. District Court for the Eastern District of Virginia
U.S. Court of Appeals for the Federal Circuit